Atiratecan(Synonyms: TP300)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白,专注于信号通路和疾病研究领域。

Atiratecan (Synonyms: TP300)

Atiratecan (TP300) 是喜树碱类似物 CH0793076 (HY-107096) 的前药。Atiratecan 不抑制乙酰胆碱酯酶 (AChE) 活性。Atiratecan 在小鼠异种移植模型中显示出对乳腺癌抗性蛋白 (BCRP) 阳性和阴性异种移植物的抗肿瘤活性。

Atiratecan(Synonyms: TP300)

Atiratecan Chemical Structure

CAS No. : 867063-97-6

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Atiratecan (TP300) is a prodrug of camptothecin analog CH0793076 (HY-107096). Atiratecan does not inhibit acetylcholinesterase (AChE) activities. Atiratecan shows antitumor activity against both breast cancer resistance protein (BCRP)-positive and -negative xenografts in mouse xenograft models[1].

体外研究
(In Vitro)

Atiratecan (TP300) is stable in an acidic solution but is rapidly converted to CH0793076 under physiological pH conditions such as in sera[1].
Atiratecan has antiproliferative activity against camptothecin-resistant cell lines. Atiratecan has IC50s of 9.4 nM and 1.1 nM for A2780 and A2780/SN75 cells, respectively[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Atiratecan (TP300; 47 mg/kg; IV; once per week for 3 weeks) shows more than 50% of tumor growth inhibition in all nine models, regardless of the expression of BCRP[1].
Atiratecan (24 mg/kg; IV; once per week for 6 weeks) in combination with capecitabine results in synergistic eVects in the HCT116 human colon cancer and NCI-N87 human gastric cancer xenograft models and an additive eVect in the WiDr human colon cancer xenograft model which is BCRP-positive and CPT-11-insensitive[1].
The eVective dose range of Atiratecan is between 0.30 and 47 mg/kg (MTD/ED50=157). The toxic dose is 63 mg/kg for Atiratecan[1].

Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Five-week-old male athymic nude mice (CAnN.CgFoxn1nu/CrlCrlj)[1]
Dosage: 47 mg/kg (the maximum tolerated dose; MTD)
Administration: IV; once per week for 3 weeks
Result: Showed more than 50% of tumor growth inhibition in all models, regardless of the expression of BCRP.

分子量

586.64

Formula

C31H34N6O6

CAS 号

867063-97-6

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

参考文献
  • [1]. Endo M, et al. A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancerresistance protein-expressing tumor xenografts. Cancer Chemother Pharmacol. 2010 Jan;65(2):363-71.

所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

发表回复